Identifying dysregulated pathways in cancers from pathway interaction networks

BMC Bioinformatics

Volumn 13, Issue 1, 2012, Pages

  Liu, Ke Qin ^a,c   Liu, Zhi Ping ^b   Hao, Jin Kao ^c   Chen, Luonan ^a,b,d   Zhao, Xing Ming ^a  

^a SHANGHAI UNIVERSITY   (China)

^b Shanghai Jiao Tong University Affiliated Sixth People s Hospital   (China)

^c UNIVERSITÉ D'ANGERS   (France)

^d INSTITUTE OF INDUSTRIAL SCIENCE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CELLULAR PATHWAY; COMPLEX DISEASE; FEATURE SELECTION PROBLEM; FUNCTIONAL DEPENDENCY; GENE EXPRESSION DATA; MULTIPLE GENES; PATHOGENIC PATHWAYS; PATHWAY INTERACTIONS; POTENTIAL DRUG TARGETS; PROTEIN-PROTEIN INTERACTIONS; SMALL SAMPLE SIZE; STATE-OF-THE-ART METHODS; SUBNETWORKS; THREE FOLDS;

ACTIVE NETWORKS; GENE EXPRESSION; PROTEINS;

DISEASES;

TUMOR MARKER;

ARTICLE; BIOLOGY; GENE EXPRESSION; GENETICS; HUMAN; METABOLISM; METHODOLOGY; NEOPLASM; PROTEIN PROTEIN INTERACTION;

COMPUTATIONAL BIOLOGY; GENE EXPRESSION; HUMANS; METABOLIC NETWORKS AND PATHWAYS; NEOPLASMS; PROTEIN INTERACTION MAPS; TUMOR MARKERS, BIOLOGICAL;

EID: 84861843896     PISSN: None     EISSN: 14712105     Source Type: Journal    
DOI: 10.1186/1471-2105-13-126     Document Type: Article

References (46)

1. Chen L, Wang R-S, Zhang X-S. Biomolecular Networks: Methods and Applications in Systems Biology 2009, John Wiley & Sons Inc, Hoboken, New Jersey.
2. Chen L, Wang R, Li C, Aihara K. Modelling Biomolecular Networks in Cells: Structures and Dynamics 2010, Springer-Verlag, London.
3. Golub TR, Slonim DK, Tamayo P, Huard C, Gaasenbeek M, Mesirov JP, Coller H, Loh ML, Downing JR, Caligiuri MA, et al. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science 1999, 286(5439):531-537. 10.1126/science.286.5439.531, 10521349.
4. Thomas JG, Olson JM, Tapscott SJ, Zhao LP. An efficient and robust statistical modeling approach to discover differentially expressed genes using genomic expression profiles. Genome Res 2001, 11(7):1227-1236. 10.1101/gr.165101, 311075, 11435405.
5. Han H, Bearss DJ, Browne LW, Calaluce R, Nagle RB, Von Hoff DD. Identification of differentially expressed genes in pancreatic cancer cells using cDNA microarray. Cancer Res 2002, 62(10):2890-2896.
6. Braga-Neto UM, Dougherty ER. Is cross-validation valid for small-sample microarray classification?. Bioinformatics 2004, 20(3):374-380. 10.1093/bioinformatics/btg419, 14960464.
7. Peltonen L, McKusick VA. Genomics and medicine. Dissecting human disease in the postgenomic era. Science 2001, 291(5507):1224-1229. 10.1126/science.291.5507.1224, 11233446.
8. Glazier AM, Nadeau JH, Aitman TJ. Finding genes that underlie complex traits. Science (New York, N Y) 2002, 298(5602):2345-2349.
9. Merikangas KR, Low NC, Hardy J. Commentary: understanding sources of complexity in chronic diseases--the importance of integration of genetics and epidemiology. Int J Epidemiol 2006, 35(3):590-592. discussion 593-596, 10.1093/ije/dyl007, 16540533.
10. Tian L, Greenberg SA, Kong SW, Altschuler J, Kohane IS, Park PJ. Discovering statistically significant pathways in expression profiling studies. Proc Natl Acad Sci U S A 2005, 102(38):13544-13549. 10.1073/pnas.0506577102, 1200092, 16174746.
11. Bild AH, Yao G, Chang JT, Wang Q, Potti A, Chasse D, Joshi MB, Harpole D, Lancaster JM, Berchuck A, et al. Oncogenic pathway signatures in human cancers as a guide to targeted therapies. Nature 2006, 439(7074):353-357. 10.1038/nature04296, 16273092.
12. Chuang HY, Lee E, Liu YT, Lee D, Ideker T. Network-based classification of breast cancer metastasis. Mol Syst Biol 2007, 3:140. 2063581, 17940530.
13. Lee E, Chuang HY, Kim JW, Ideker T, Lee D. Inferring pathway activity toward precise disease classification. PLoS Comput Biol 2008, 4(11):e1000217. 10.1371/journal.pcbi.1000217, 2563693, 18989396.
14. Li Y, Agarwal P. A pathway-based view of human diseases and disease relationships. PLoS One 2009, 4(2):e4346. 10.1371/journal.pone.0004346, 2631151, 19194489.
15. Su J, Yoon BJ, Dougherty ER. Accurate and reliable cancer classification based on probabilistic inference of pathway activity. PLoS One 2009, 4(12):e8161. 10.1371/journal.pone.0008161, 2781165, 19997592.
16. Gatza ML, Lucas JE, Barry WT, Kim JW, Wang Q, Crawford MD, Datto MB, Kelley M, Mathey-Prevot B, Potti A, et al. A pathway-based classification of human breast cancer. Proc Natl Acad Sci U S A 2010, 107(15):6994-6999. 10.1073/pnas.0912708107, 2872436, 20335537.
17. Ulitsky I, Krishnamurthy A, Karp RM, Shamir R. DEGAS: de novo discovery of dysregulated pathways in human diseases. PLoS One 2010, 5(10):e13367. 10.1371/journal.pone.0013367, 2957424, 20976054.
18. Liu Z-P, Wang Y, Zhang X-S, Chen L. Identifying dysfunctional crosstalk of pathways in various regions of Alzheimer's disease brains. BMC Syst Biol 2010, 4(Suppl 2):S11. 10.1186/1752-0509-4-S2-S11, 2982685, 20840725.
19. Edgar R, Domrachev M, Lash AE. Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res 2002, 30(1):207-210. 10.1093/nar/30.1.207, 99122, 11752295.
20. Spira A, Beane JE, Shah V, Steiling K, Liu G, Schembri F, Gilman S, Dumas YM, Calner P, Sebastiani P, et al. Airway epithelial gene expression in the diagnostic evaluation of smokers with suspect lung cancer. Nat Med 2007, 13(3):361-366. 10.1038/nm1556, 17334370.
21. Chandran UR, Ma C, Dhir R, Bisceglia M, Lyons-Weiler M, Liang W, Michalopoulos G, Becich M, Monzon FA. Gene expression profiles of prostate cancer reveal involvement of multiple molecular pathways in the metastatic process. BMC Cancer 2007, 7:64. 10.1186/1471-2407-7-64, 1865555, 17430594.
22. Pau Ni IB, Zakaria Z, Muhammad R, Abdullah N, Ibrahim N, Aina Emran N, Hisham Abdullah N, Syed Hussain SN. Gene expression patterns distinguish breast carcinomas from normal breast tissues: the Malaysian context. Pathol Res Pract 2010, 20(4):223-228.
23. Pei H, Li L, Fridley BL, Jenkins GD, Kalari KR, Lingle W, Petersen G, Lou Z, Wang L. FKBP51 affects cancer cell response to chemotherapy by negatively regulating Akt. Cancer Cell 2009, 16(3):259-266. 10.1016/j.ccr.2009.07.016, 2755578, 19732725.
24. Liberzon A, Subramanian A, Pinchback R, Thorvaldsdottir H, Tamayo P, Mesirov JP. Molecular signatures database (MSigDB) 3.0. Bioinformatics 2011, 27(12):1739-1740. 10.1093/bioinformatics/btr260, 3106198, 21546393.
25. Kanehisa M, Araki M, Goto S, Hattori M, Hirakawa M, Itoh M, Katayama T, Kawashima S, Okuda S, Tokimatsu T, et al. KEGG for linking genomes to life and the environment. Nucleic Acids Res 2008, 36(Database issue):D480-D484. 2238879, 18077471.
26. Matthews L, Gopinath G, Gillespie M, Caudy M, Croft D, De Bono B, Garapati P, Hemish J, Hermjakob H, Jassal B, et al. Reactome knowledgebase of human biological pathways and processes. Nucleic Acids Res 2009, 37(Database issue):D619-D622. 2686536, 18981052.
27. Keshava Prasad TS, Goel R, Kandasamy K, Keerthikumar S, Kumar S, Mathivanan S, Telikicherla D, Raju R, Shafreen B, Venugopal A, et al. Human Protein Reference Database--2009 update. Nucleic Acids Res 2009, 37(Database issue):D767-D772. 2686490, 18988627.
28. Hotelling H. Analysis of a Complex of Statistical Variables into Principal Components. Journal of Educational Psychology 1933, 24(6):417-441.
29. Chang C-C, Lin C-J. LIBSVM: a library for support vector machines 2001, , .
30. Baumgartner C, Baumgartner D. Biomarker discovery, disease classification, and similarity query processing on high-throughput MS/MS data of inborn errors of metabolism. J Biomol Screen 2006, 11(1):90-99.
31. Lee IH, Lushington GH, Visvanathan M. A filter-based feature selection approach for identifying potential biomarkers for lung cancer. J Clin Bioinforma 2011, 1(1):11. 10.1186/2043-9113-1-11, 3164604, 21884628.
32. Stearman RS, Dwyer-Nield L, Zerbe L, Blaine SA, Chan Z, Bunn PA, Johnson GL, Hirsch FR, Merrick DT, Franklin WA, et al. Analysis of orthologous gene expression between human pulmonary adenocarcinoma and a carcinogen-induced murine model. Am J Pathol 2005, 167(6):1763-1775. 10.1016/S0002-9440(10)61257-6, 1613183, 16314486.
33. Su LJ, Chang CW, Wu YC, Chen KC, Lin CJ, Liang SC, Lin CH, Whang-Peng J, Hsu SL, Chen CH, et al. Selection of DDX5 as a novel internal control for Q-RT-PCR from microarray data using a block bootstrap re-sampling scheme. BMC Genomics 2007, 8:140. 10.1186/1471-2164-8-140, 1894975, 17540040.
34. Landi MT, Dracheva T, Rotunno M, Figueroa JD, Liu H, Dasgupta A, Mann FE, Fukuoka J, Hames M, Bergen AW, et al. Gene expression signature of cigarette smoking and its role in lung adenocarcinoma development and survival. PLoS One 2008, 3(2):e1651. 10.1371/journal.pone.0001651, 2249927, 18297132.
35. Wang X, Chorley BN, Pittman GS, Kleeberger SR, Brothers J, Liu G, Spira A, Bell DA. Genetic variation and antioxidant response gene expression in the bronchial airway epithelium of smokers at risk for lung cancer. PLoS One 2010, 5(8):e11934. 10.1371/journal.pone.0011934, 2914741, 20689807.
36. Levine AJ, Oren M. The first 30 years of p53: growing ever more complex. Nat Rev Cancer 2009, 9(10):749-758. 10.1038/nrc2723, 2771725, 19776744.
37. Wagner EF, Nebreda AR. Signal integration by JNK and p38 MAPK pathways in cancer development. Nat Rev Cancer 2009, 9(8):537-549. 10.1038/nrc2694, 19629069.
38. Cheng Y, Qiu F, Tashiro S, Onodera S, Ikejima T. ERK and JNK mediate TNFalpha-induced p53 activation in apoptotic and autophagic L929 cell death. Biochem Biophys Res Commun 2008, 376(3):483-488. 10.1016/j.bbrc.2008.09.018, 18796294.
39. Rayet B, Gelinas C. Aberrant rel/nfkb genes and activity in human cancer. Oncogene 1999, 18(49):6938-6947. 10.1038/sj.onc.1203221, 10602468.
40. Zhang S, Lin ZN, Yang CF, Shi X, Ong CN, Shen HM. Suppressed NF-kappaB and sustained JNK activation contribute to the sensitization effect of parthenolide to TNF-alpha-induced apoptosis in human cancer cells. Carcinogenesis 2004, 25(11):2191-2199. 10.1093/carcin/bgh234, 15256485.
41. Jimenez C, Portela RA, Mellado M, Rodriguez-Frade JM, Collard J, Serrano A, Martinez AC, Avila J, Carrera AC. Role of the PI3K regulatory subunit in the control of actin organization and cell migration. J Cell Biol 2000, 151(2):249-262. 10.1083/jcb.151.2.249, 2192656, 11038173.
42. Vivanco I, Sawyers CL. The phosphatidylinositol 3-Kinase AKT pathway in human cancer. Nat Rev Cancer 2002, 2(7):489-501. 10.1038/nrc839, 12094235.
43. Asano T, Yao Y, Zhu J, Li D, Abbruzzese JL, Reddy SA. The PI 3-kinase/Akt signaling pathway is activated due to aberrant Pten expression and targets transcription factors NF-kappaB and c-Myc in pancreatic cancer cells. Oncogene 2004, 23(53):8571-8580. 10.1038/sj.onc.1207902, 15467756.
44. Wang J, Huang Q, Liu ZP, Wang Y, Wu LY, Chen L, Zhang XS. NOA: a novel Network Ontology Analysis method. Nucleic Acids Res 2011, 39(13):e87. 10.1093/nar/gkr251, 3141273, 21543451.
45. He D, Liu ZP, Chen L. Identification of dysfunctional modules and disease genes in congenital heart disease by a network-based approach. BMC Genomics 2011, 12:592. 10.1186/1471-2164-12-592, 3256240, 22136190.
46. Chen L, Liu R, Liu ZP, Li M, Aihara K. Detecting early-warning signals for sudden deterioration of complex diseases by dynamical network biomarkers. Sci Rep 2012, 2:342. 3314989, 22461973.